<doc>
  <docmeta id="113s1453is">
    <bill congress="113" type="s" number="1453" version="is"/>
    <revision size="12229" annotations="0" status="complete" id="6" commit-time="2013-08-23T19:19:32Z" committer="mbohmer" doc="113s1453is/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S1453 IS: Pulmonary Hypertension Research and Diagnosis Act of 2013</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2013-08-01</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 1453</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130801">August 1, 2013</action-date>
			<action-desc>
        <sponsor name-id="S309">Mr. Casey</sponsor> introduced the
			 following bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To direct the Secretary of Health and Human Services to
		  establish an interagency coordinating committee on pulmonary hypertension to
		  develop recommendations to advance research, increase awareness and education,
		  and improve health and health care, and for other purposes.</official-title>
	</form>
	<legis-body id="HC966DB7D95D149B6B9B8D8337FDDD325" style="OLC">
		<section id="H49C0FB9F87F649D080232DC11B10BE4A" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Pulmonary Hypertension Research and
			 Diagnosis Act of 2013</short-title>
        </quote>.</text>
		</section>
    <section id="HFB84FC6424E24DBAB4E648DD2583CB8C">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds as follows:</text>
			<paragraph id="H3CCEF2C4B46C468B96093DDC4C888968">
        <enum>(1)</enum>
        <text>Pulmonary
			 hypertension is a serious, debilitating, and often fatal progressive condition
			 where the blood pressure in the lungs rises to dangerously high levels. In
			 pulmonary hypertension patients, the walls of the arteries that take blood from
			 the right side of the heart to the lungs thicken and constrict. As a result,
			 the right side of the heart has to pump harder to move blood into the lungs,
			 causing it to enlarge and ultimately fail.</text>
			</paragraph>
      <paragraph id="HDAF3204CD9B64108BBAF6036A1C45900">
        <enum>(2)</enum>
        <text>In advanced stages
			 of pulmonary hypertension, the patient is able to perform only minimal activity
			 and has symptoms even when resting, resulting in considerable disability. The
			 disease may worsen to the point where the patient is completely bedridden. In a
			 matter of months, many pulmonary hypertension patients have become so
			 functionally deteriorated that they have lost their jobs and are dependent on
			 family and disability benefits.</text>
			</paragraph>
      <paragraph id="H9A5896DDF25B410188FFD5E433E42F64">
        <enum>(3)</enum>
        <text>Despite the
			 importance of early diagnosis on prognosis, pulmonary hypertension is rarely
			 picked up in a routine medical exam. Even in its later stages, the signs of the
			 disease are frequently confused with more common conditions that affect the
			 heart and lungs. Due to the fact that the average length of time between the
			 onset of symptoms and an accurate diagnosis is presently 2.8 years, nearly
			 three out of four patients have advanced pulmonary hypertension by the time
			 they are accurately diagnosed.</text>
			</paragraph>
      <paragraph id="H41745B564DDB48B194CA362FE137DDC8">
        <enum>(4)</enum>
        <text>While pulmonary
			 hypertension remains an incurable condition, progress in our scientific
			 understanding of the disease has led to the development and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug
			 Administration</cato:entity-ref> approval of nine innovative therapies indicated to treat
			 pulmonary hypertension.</text>
			</paragraph>
      <paragraph id="HABE9C587C6AB464198FCD3AF506D5D19">
        <enum>(5)</enum>
        <text>Existing treatment
			 options can significantly extend life and improve quality of life for patients
			 with pulmonary hypertension. The effectiveness of pulmonary hypertension
			 treatment options is directly tied to how early in the progression of the
			 condition a patient can be accurately diagnosed and begin the correct regimen
			 of therapies. Improved early intervention will improve health outcomes for
			 pulmonary hypertension patients while reducing the necessity for more drastic
			 and costly treatment options, such as a lung or heart-lung transplant.</text>
			</paragraph>
    </section>
    <section id="H0A007B94438342949BCA54650686FE32">
      <enum>3.</enum>
      <header>Interagency
			 pulmonary hypertension coordinating committee</header>
			<subsection id="HC36ADC30FE1E4C748A46A0868F4E7BD1">
        <enum>(a)</enum>
        <header>Establishment</header>
        <text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref> (in this Act referred to as the
			 <quote>Secretary</quote>) shall establish a committee, to be known as the
			 <quote>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Interagency Pulmonary Hypertension Coordinating Committee</cato:entity-ref>
          </quote> (in
			 this Act referred to as the <quote>Committee</quote>), to make recommendations
			 on, and coordinate, all efforts within the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Department of Health and Human
			 Services</cato:entity-ref> concerning pulmonary hypertension.</text>
			</subsection>
      <subsection id="HC7FC7730B26445D3A61CFE997FCF6377">
        <enum>(b)</enum>
        <header>Responsibilities</header>
        <text>In
			 carrying out its duties under this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref> shall—</text>
				<paragraph id="HE923174D07984CA78564FA3C76E801B4">
          <enum>(1)</enum>
          <text>develop and
			 annually update a summary of pulmonary hypertension advances in medical
			 research and treatment development and improvement, early and accurate
			 diagnosis, appropriate and timely intervention, transplantation, and access to
			 care and therapies for patients;</text>
				</paragraph>
        <paragraph id="HAABAAED918194642824A1AB0FF2BE452">
          <enum>(2)</enum>
          <text>monitor Federal
			 activities with respect to pulmonary hypertension;</text>
				</paragraph>
        <paragraph id="H5DF40F8823994485974750F031296EFD">
          <enum>(3)</enum>
          <text>make
			 recommendations to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding appropriate changes to such
			 activities, including recommendations with respect to the strategic plan
			 developed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pulmonary Hypertension Research and Diagnosis Act of 2013/s:3/ss:b/p:5" proposed="true">paragraph (5)</cato:entity-ref>;</text>
				</paragraph>
        <paragraph id="HB83F148F4875425B842DE1EE8510E69D">
          <enum>(4)</enum>
          <text>make
			 recommendations to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> regarding stakeholder participation in
			 decisions relating to pulmonary hypertension;</text>
				</paragraph>
        <paragraph id="H7BE8EAF64715423FA6F685CB7CDC5806">
          <enum>(5)</enum>
          <text>develop and
			 annually update a comprehensive strategic plan to cooperatively improve health
			 outcomes for pulmonary hypertension patients which includes—</text>
					<subparagraph id="HC39D26E09CEB43DD84BFD616BA5EC283">
            <enum>(A)</enum>
            <text>recommendations to
			 improve professional education concerning accurate diagnosis and appropriate
			 intervention for health care providers;</text>
					</subparagraph>
          <subparagraph id="HE08593C03E8741BF9C3F47DBA8710701">
            <enum>(B)</enum>
            <text>recommendations to
			 improve the transplantation criteria and process concerning lung and heart-lung
			 transplants for pulmonary hypertension patients;</text>
					</subparagraph>
          <subparagraph id="HE87EF15B60F64160976F47503E05AB79">
            <enum>(C)</enum>
            <text>recommendations to
			 improve public awareness and recognition of pulmonary hypertension;</text>
					</subparagraph>
          <subparagraph id="H7DE4FB1211924F48AADFC7FFD790D72B">
            <enum>(D)</enum>
            <text>recommendations to
			 improve health care delivery and promote early and accurate diagnosis for
			 pulmonary hypertension patients; and</text>
					</subparagraph>
          <subparagraph id="HD059125C97BF42728B31FE790AE290CF">
            <enum>(E)</enum>
            <text>recommendations to
			 systematically advance the full spectrum of biomedical research, including
			 specific recommendations for basic, translational, clinical, and pediatric
			 research, and research training and career development; and</text>
					</subparagraph>
        </paragraph>
        <paragraph id="H747D2F15C65A4336A2D421C4A0317D2C">
          <enum>(6)</enum>
          <text>submit to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> the strategic plan under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pulmonary Hypertension Research and Diagnosis Act of 2013/s:3/ss:b/p:5" proposed="true">paragraph (5)</cato:entity-ref> and any updates to such
			 plan.</text>
				</paragraph>
      </subsection>
      <subsection id="H6687C0DC00D04B33941430EA02489A5A">
        <enum>(c)</enum>
        <header>Membership</header>
				<paragraph id="HF98295D63A73476497BDA709F7E31E51">
          <enum>(1)</enum>
          <header>In
			 general</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7000" proposed="true">Committee</cato:entity-ref> shall be composed of—</text>
					<subparagraph id="H2596377AA0074348B55465A57D755CE1">
            <enum>(A)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7526">Administrator
			 of the Health Resources and Services Administration</cato:entity-ref>;</text>
					</subparagraph>
          <subparagraph id="H900BE54BC64F4D3C8E6FF157418E048B">
            <enum>(B)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of
			 the Centers for Disease Control and Prevention</cato:entity-ref> and the directors of such
			 centers at the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease Control and Prevention</cato:entity-ref> as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
			 determines appropriate;</text>
					</subparagraph>
          <subparagraph id="H988FB944D27A4FEBA4A3E4F724C136C4">
            <enum>(C)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of
			 the National Institutes of Health</cato:entity-ref> and the directors of such institutes,
			 centers, and offices at the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">National Institutes of Health</cato:entity-ref> as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
			 determines appropriate;</text>
					</subparagraph>
          <subparagraph id="H238677C4B31649A4BAC94F9E3DBB2D2A">
            <enum>(D)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7528">Director of
			 the Agency for Healthcare Research and Quality</cato:entity-ref>;</text>
					</subparagraph>
          <subparagraph id="H7E42CB38D45945F0BBC550B3DBF67D45">
            <enum>(E)</enum>
            <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner
			 of Food and Drugs</cato:entity-ref> and the directors of such centers and offices at the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and
			 Drug Administration</cato:entity-ref> as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines appropriate;</text>
					</subparagraph>
          <subparagraph id="H0AA99FB26AC0477580B7B370B996B6C3">
            <enum>(F)</enum>
            <text>the heads of other
			 relevant agencies as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> deems appropriate; and</text>
					</subparagraph>
          <subparagraph id="H6A88B8ABF6D5439AB45BE28BA97D1558">
            <enum>(G)</enum>
            <text>the additional
			 members appointed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pulmonary Hypertension Research and Diagnosis Act of 2013/s:3/ss:c/p:2" proposed="true">paragraph (2)</cato:entity-ref>.</text>
					</subparagraph>
        </paragraph>
        <paragraph id="HFF8ED8D53DD640EAB5396C98E1C87B5F">
          <enum>(2)</enum>
          <header>Additional
			 members</header>
          <text>Not fewer than 6 members of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref> or
			 <fraction>1/3</fraction> of the total membership of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref>, whichever is
			 greater, shall be composed of non-Federal public members to be appointed by the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, of which—</text>
					<subparagraph id="H475E4E4D4F6546A78C0A9C04CD5EFDAD">
            <enum>(A)</enum>
            <text>at least one such
			 member shall be an individual with a diagnosis of pulmonary
			 hypertension;</text>
					</subparagraph>
          <subparagraph id="H03F6B507A601419F8AC99B198D84CCB9">
            <enum>(B)</enum>
            <text>at least one such
			 member shall be the primary caregiver for an individual with a diagnosis of
			 pulmonary hypertension; and</text>
					</subparagraph>
          <subparagraph id="H4310F80C8C394A9AB663521FB66F17F4">
            <enum>(C)</enum>
            <text>at least one such
			 member shall be a representative of a leading research, advocacy, and support
			 organization primarily serving individuals with a diagnosis of pulmonary
			 hypertension.</text>
					</subparagraph>
        </paragraph>
      </subsection>
      <subsection id="H4D66D334105843D2B4E615673FFEB77F">
        <enum>(d)</enum>
        <header>Administrative
			 support; terms of service; other provisions</header>
        <text>The following
			 provisions shall apply with respect to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref>:</text>
				<paragraph id="H7867DF623761410888DD41F503226771">
          <enum>(1)</enum>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref>
			 shall receive necessary and appropriate administrative support from the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="HD8B4BA432F5F4A509F34FAE1D4AE91B8">
          <enum>(2)</enum>
          <text>Members of the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref> appointed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pulmonary Hypertension Research and Diagnosis Act of 2013/s:3/ss:c/p:2" proposed="true">subsection (c)(2)</cato:entity-ref> shall serve for a term of 4 years,
			 and may be appointed for one or more additional 4-year terms. Any member
			 appointed to fill a vacancy for an unexpired term shall be appointed for the
			 remainder of such term. A member may serve after the expiration of the member’s
			 term until a successor has taken office.</text>
				</paragraph>
        <paragraph id="HF3FD9927A57941E88D4D927374F76E5E">
          <enum>(3)</enum>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref>
			 shall meet at the call of the chairperson or upon the request of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.
			 The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref> shall meet not fewer than two times each year.</text>
				</paragraph>
        <paragraph id="H1564CE3E776F404ABB1C0D3D6823985D">
          <enum>(4)</enum>
          <text>All meetings of
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref> shall be public and shall include appropriate time periods for
			 questions and presentations by the public.</text>
				</paragraph>
      </subsection>
      <subsection id="H7BC80DEFBE9E4DFCA46B224BEB8556FD">
        <enum>(e)</enum>
        <header>Subcommittees;
			 establishment and membership</header>
        <text>In carrying out its functions, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref> may establish subcommittees and convene workshops and conferences.
			 Such subcommittees shall be composed of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref> members and may hold such
			 meetings as are necessary to enable the subcommittees to carry out their
			 duties.</text>
			</subsection>
    </section>
    <section id="HA1ABBEAAF566486ABDE7701B7C508A8B">
      <enum>4.</enum>
      <header>Report to
			 Congress</header>
			<subsection id="HDB12CC6E3A644731A6E12103394E3549">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text>Not later than one year after the date of enactment of
			 this Act, and biennially thereafter, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, in coordination with the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Committee</cato:entity-ref>, shall prepare and submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="SSHR00">Committee on Health, Education,
			 Labor, and Pensions of the Senate</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="HIF00">Committee on Energy and Commerce
			 Committee of the House of Representatives</cato:entity-ref> a progress report on activities
			 related to improving health outcomes for pulmonary hypertension
			 patients.</text>
			</subsection>
      <subsection id="H630469C6F06B4125BBE156AB29E22C8B">
        <enum>(b)</enum>
        <header>Contents</header>
        <text>The
			 report submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pulmonary Hypertension Research and Diagnosis Act of 2013/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall contain—</text>
				<paragraph id="H22C1A1E03EBE4063923276E4EF55BB88">
          <enum>(1)</enum>
          <text>information on the
			 incidence of pulmonary hypertension and trend data of such incidence since the
			 date of enactment of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Pulmonary Hypertension Research and Diagnosis Act of 2013" proposed="true">Pulmonary Hypertension Research and Diagnosis Act of
			 2013</cato:entity-ref>;</text>
				</paragraph>
        <paragraph id="H1FC5806F2E444B36A29A2521E30F6048">
          <enum>(2)</enum>
          <text>information on the
			 average time between initial screening and accurate diagnosis as well as the
			 average stage of pulmonary hypertension when appropriate intervention begins
			 and up-to-date, related trend data;</text>
				</paragraph>
        <paragraph id="H4E02D4653E8B488383D152C44ADAE965">
          <enum>(3)</enum>
          <text>information on the
			 effectiveness and outcomes of interventions for individuals diagnosed with
			 pulmonary hypertension, including—</text>
					<subparagraph id="H965192B66BF94C38AA8A8C89714C011A">
            <enum>(A)</enum>
            <text>mortality rate, as
			 well as the frequency of drastic treatment options like lung and heart-lung
			 transplants; and</text>
					</subparagraph>
          <subparagraph id="HE2DE6005438D4E449D2B42E280C4A742">
            <enum>(B)</enum>
            <text>up-to-date,
			 related trend data;</text>
					</subparagraph>
        </paragraph>
        <paragraph id="H4C08FCD03DD84197A0321E6056F2ADA3">
          <enum>(4)</enum>
          <text>information on
			 breakthroughs in basic science as well as translational and clinical research
			 activities;</text>
				</paragraph>
        <paragraph id="H8BFE20F97CD44F35866EF3DEB007CDA1">
          <enum>(5)</enum>
          <text>information on
			 activity to facilitate the development of innovative treatment options and
			 diagnostic tools; and</text>
				</paragraph>
        <paragraph id="H232B110C77F6415AB979D95EA1EC8CA5">
          <enum>(6)</enum>
          <text>information on
			 services and supports provided to individuals with a diagnosis of pulmonary
			 hypertension.</text>
				</paragraph>
      </subsection>
    </section>
    <section id="HEA1973C64FBF49E6B5B44BD0355AAD2B">
      <enum>5.</enum>
      <header>Sunset</header>
      <text display-inline="no-display-inline">This Act shall not apply after September 30,
			 2018, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Interagency Pulmonary Hypertension Coordinating Committee" entity-parent-id="7500" proposed="true">Interagency Pulmonary Hypertension Coordinating Committee</cato:entity-ref> shall
			 be terminated on such date.</text>
		</section>
  </legis-body>
</bill>
</doc>